Startup Daily21d
Respiratory care biotech Diag-Nose sniffs out $3.15 million Seed round
“Together with the new biologics medicines, our RhinoMAP system will bring us one step closer towards the holy grail of respiratory medicine; helping patients become completely free of symptoms,” he ...
WDTN22d
Diag-Nose.io Projected to Enhance Global Respiratory Care Markets Following Oversubscribed $2M Seed Funding
Together with new biologic therapies, we hope our RhinoMAP™ system will take us one step closer to the holy grail of respiratory medicine; helping patients be completely free of symptoms.
Yahoo Finance22d
Diag-Nose.io Opens Houston Office following oversubscribed $2M Seed Round to Measure Respiratory Treatment Success Using Proteomics & AI
HOUSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Diag-Nose.io, a cutting-edge biotech company pioneering precision medicine for respiratory disorders, has announced the opening of its new office in ...
Yahoo Finance22d
Diag-Nose.io, Graduate of CDL-Seattle, Closes Oversubscribed $2M Seed Round to Transform Respiratory Care with AI-Driven Precision Medicine
SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- A groundbreaking precision medicine system developed by biotech trailblazer Diag-Nose.io hopes to transform the management of chronic respiratory diseases ...
premier.vic.gov.au22d
Investing In Medtech So Patients Can Breathe Easier
Melbourne-based company Diag-Nose has developed its flagship diagnostic tool RhinoMAP using artificial intelligence to map the biological makeup of a patient’s respiratory system so the most effective ...
TMCnet22d
Diag-Nose.io, Graduate of CDL-Seattle, Closes Oversubscribed $2M Seed Round to Transform Respiratory Care with AI-Driven Precision Medicine
“Togethe with the new biologics medicines, our RhinoMAP™ system will bring us one step closer towards the holy grail of respiratory medicine; helping patients become completely free of symptoms. This ...